<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XBRL Optimizer.xfr; Date: 2013/08/08T23:38:56 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:OPRX="http://OPRX/20130630">
    <link:schemaRef xlink:href="oprx-20130630.xsd" xlink:type="simple" />
    <xbrli:context id="From2013-01-01to2013-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-04-01to2013-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-04-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-04-01to2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2008-04-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2008-04-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-01-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-01-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-07-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-07-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-01-01to2008-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-01-01</xbrli:startDate>
        <xbrli:endDate>2008-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-01-01to2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-01-01</xbrli:startDate>
        <xbrli:endDate>2010-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-09-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-05-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-05-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-11-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-12-01to2014-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-12-01</xbrli:startDate>
        <xbrli:endDate>2014-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-12-02to2016-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-12-02</xbrli:startDate>
        <xbrli:endDate>2016-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-05-31_ThreeEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:ThreeEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-12-31_ThreeEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:ThreeEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-05-30_ThreeEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:ThreeEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31_TwoEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:TwoEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-12-31_TwoEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:TwoEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-06-30_TwoEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:TwoEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-11-21_IndividualStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:IndividualStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-11-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-12-31_IndividualStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:IndividualStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-06-30_IndividualStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:IndividualStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31_FourNonEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:FourNonEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-06-30_FourNonEmployeesStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:FourNonEmployeesStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_NonEmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:NonEmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-10-01to2012-12-31_NonEmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:NonEmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-10-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-06-30_NonEmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:NonEmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2013-01-01to2013-06-30">OptimizeRx Corp</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2013-01-01to2013-06-30">0001448431</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2013-01-01to2013-06-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2013-01-01to2013-06-30">2013-06-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2013-01-01to2013-06-30">false</dei:AmendmentFlag>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2013-01-01to2013-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2013-01-01to2013-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2013-01-01to2013-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2013-01-01to2013-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2013-01-01to2013-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2013-01-01to2013-06-30">2013</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">14252496</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">352432</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">284263</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">939685</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">616798</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">55719</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">68158</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">1347836</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">969219</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">17871</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">20685</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">803136</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">793236</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">322070</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">387215</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:SecurityDeposit contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
    <us-gaap:OtherAssets contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">1130255</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">1185500</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">2495962</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">2175404</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">12150</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">54693</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">87500</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DeferredRevenue contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">42620</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">49252</us-gaap:DeferredRevenue>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">712270</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">679945</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">14252</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">14232</us-gaap:CommonStockValue>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">20058051</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">20058051</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">6203546</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6164666</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">-24492157</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-24741490</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">1783692</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">1495459</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">2495962</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">2175404</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockValue contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:SalesRevenueNet contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">1773377</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">1104087</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">515423</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">844826</us-gaap:SalesRevenueNet>
    <us-gaap:Revenues contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">1773377</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">1104087</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">515423</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">844826</us-gaap:Revenues>
    <us-gaap:OperatingCostsAndExpenses contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">1524138</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">749966</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">591628</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">1221952</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:InterestAndOtherIncome contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">94</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">38</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">146</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">331</us-gaap:InterestAndOtherIncome>
    <us-gaap:OtherExpenses contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">94</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">38</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">146</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">331</us-gaap:OtherExpenses>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:OperatingExpenses contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">1524138</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">749966</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">591628</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">1221952</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">249239</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">354121</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76205</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-377126</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">249333</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">354159</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76059</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-376795</us-gaap:IncomeLossFromContinuingOperations>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">249333</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">354159</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76059</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-376795</OPRX:LossBeforeProvisionForIncomeTaxes>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">14235700</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2013-04-01to2013-06-30" unitRef="Shares" decimals="INF">14238870</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2012-04-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">33608304</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2013-04-01to2013-06-30" unitRef="Shares" decimals="INF">33608304</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2012-04-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2013-01-01to2013-06-30" unitRef="USDPShares" decimals="INF">0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2013-04-01to2013-06-30" unitRef="USDPShares" decimals="INF">0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-04-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2013-01-01to2013-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2013-04-01to2013-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2012-04-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2013-06-30" unitRef="USDPShares" decimals="INF">.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">14252496</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">14232496</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2013-06-30" unitRef="USDPShares" decimals="INF">.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">65</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">65</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">96337</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">48226</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">47329</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">93352</us-gaap:DepreciationAndAmortization>
    <OPRX:StockIssuedForServices contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">38900</OPRX:StockIssuedForServices>
    <OPRX:StockIssuedForServices contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</OPRX:StockIssuedForServices>
    <OPRX:StockbasedCompensation contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</OPRX:StockbasedCompensation>
    <OPRX:StockbasedCompensation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">178304</OPRX:StockbasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-322887</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-54177</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">12439</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">62347</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-42543</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-158502</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">81500</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-66700</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-6632</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-53529</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">2230</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CapitalizedComputerSoftwareAmortization contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:CapitalizedComputerSoftwareAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-53725</us-gaap:CapitalizedComputerSoftwareAmortization>
    <OPRX:CashAndCashEquivalentsBeginning contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">284263</OPRX:CashAndCashEquivalentsBeginning>
    <OPRX:CashAndCashEquivalentsBeginning contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">959166</OPRX:CashAndCashEquivalentsBeginning>
    <OPRX:CashAndCashEquivalentsEnding contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">352432</OPRX:CashAndCashEquivalentsEnding>
    <OPRX:CashAndCashEquivalentsEnding contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">527511</OPRX:CashAndCashEquivalentsEnding>
    <us-gaap:InterestPaid contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">249333</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-376795</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">106447</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-375700</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <OPRX:PatentRights contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-38278</OPRX:PatentRights>
    <OPRX:PatentRights contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</OPRX:PatentRights>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-38278</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-55955</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">68169</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-431655</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:NatureOfOperations contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Optimizer&#13;Systems, LLC was formed in the State of Michigan on January 31, 2006. It then became a corporation in the State of Michigan on&#13;October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated&#13;a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which&#13;the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation&#13;for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April&#13;30, 2008, RFID&amp;#146;s officers and directors resigned their positions and RFID changed its business to OptimizeRx&amp;#146;s business.&#13;On April 15, 2008, RFID, Ltd.&amp;#146;s corporate name was changed to OptimizeRx Corporation. On September 4, 2008, a migratory merger&#13;was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure,&#13;in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation,&#13;is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;wholly-owned subsidiary, OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Their objective&#13;is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology.&#13;Once defined as a marketing and advertising company through its consumer website, OptimizeRx is maturing as a technology solutions&#13;provider as it launched its direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available&#13;sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution can either sit on the doctor&amp;#146;s&#13;desktop or can be integrated into the ePrescribing or Electronic Medical Records applications. OptimizeRx solutions provide pharmaceutical&#13;manufacturers either a direct to consumer and/or direct to physician channels for communicating and promoting their products.&#13;It provides health care providers a means to provide sampling and coupons without having to physically store samples on site,&#13;and it provides better access and affordability to the patients.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <OPRX:EntityIncorporationDateOfOrganization contextRef="From2013-01-01to2013-06-30">2006-01-31</OPRX:EntityIncorporationDateOfOrganization>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2013-01-01to2013-06-30">2007-10-22</dei:EntityIncorporationDateOfIncorporation>
    <OPRX:CapitalStockOfOptimizerxCorporationExchangedForCommonStockOfRFID contextRef="AsOf2008-04-18" unitRef="Shares" decimals="INF">1256958</OPRX:CapitalStockOfOptimizerxCorporationExchangedForCommonStockOfRFID>
    <OPRX:Ownership contextRef="AsOf2008-04-18" unitRef="Percent" decimals="INF">1.00</OPRX:Ownership>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Basis&#13;of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally&#13;accepted in the United States of America and the rules of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;), and should&#13;be read in conjunction with the audited financial statements and notes thereto contained in the Company&amp;#146;s Form 10-K filed&#13;with the SEC as of and for the year ended December 31, 2012. In the opinion of management, all adjustments necessary for the financial&#13;statements to be not misleading for the interim periods presented have been reflected herein. The results of operations for interim&#13;periods are not necessarily indicative of the results to be expected for the full year.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Accounting&#13;Basis&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (&amp;#147;GAAP&amp;#148;&#13;accounting). The Company has adopted a December 31 fiscal year end.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Principles&#13;of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary&#13;OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Cash&#13;and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity&#13;of three months or less to be cash equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Fair&#13;Value of Financial Instruments&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of cash, accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable&#13;&amp;#150; related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due&#13;to their short-term nature. The fair value of long-term debt, which approximates its carrying value, is based on current rates&#13;at which the Company could borrow funds with similar remaining maturities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Accounts&#13;Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period&#13;the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables&#13;based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience&#13;is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly&#13;assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables&#13;or reserve estimates. Bad debt expense was $0 for the six months ended June 30, 2013 and 2012, respectively. The allowance for&#13;doubtful accounts was $0 as of June 30, 2013 and December 31, 2012, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Property&#13;and Equipment&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;capital assets are being depreciated over their estimated useful lives, three to seven years using the straight-line method of&#13;depreciation for book purposes.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Revenue&#13;Recognition&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;All&#13;revenue is recognized when it is earned. Revenues are generated either through the Company&amp;#146;s website activities, in which&#13;we earn revenue from advertising and lead generation activities, or from our SampleMD activities, which include offering setup&#13;within the systems and our offers, coupons, and vouchers that enable our customers to save money on medical products and services.&#13;The Company&amp;#146;s processes are monitored by third parties who collect revenues from clients on a per activity basis and report&#13;and forward the revenue to the Company&amp;#146;s account.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Research&#13;and Development&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#146;s key members are part of a continual research development team and monitor new technologies, trends, services and&#13;partnerships that can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the&#13;patients it serves.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company seeks to educate team members through understanding of all market dynamics that have the potential to affect the business&#13;both short term and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes,&#13;as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet&#13;this mission through technology, better user experiences and new ways to engage industries to provide new support for patients&#13;needing their products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms&#13;provide robust opportunities and growth during the next five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Income&#13;Taxes&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income&#13;taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and&#13;liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and&#13;are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax&#13;assets that, based on available evidence, are not expected to be realized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Concentration&#13;of Credit Risks&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits.&#13;The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be&#13;at risk if the bank experiences financial difficulties.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Use of&#13;Estimates&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates&#13;and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported&#13;amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable&#13;lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Earnings&#13;Per Common and Common Equivalent Share&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during&#13;the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during&#13;the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method&#13;and the average market price per share during the year. Options, warrants and convertible preferred stock which are common stock&#13;equivalents are not included in the diluted earnings per share calculation for June 30, 2012since their effect is anti-dilutive.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Impairment&#13;of Long-Lived Assets&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may&#13;not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived&#13;assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows.&#13;If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss&#13;based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower&#13;of the carrying amount or the fair value less costs to sell.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Recently&#13;Issued Accounting Guidance&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#146;s&#13;results of operations, financial position or cash flow.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The accompanying unaudited&#13;interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the&#13;United States of America and the rules of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;), and should be read in conjunction&#13;with the audited financial statements and notes thereto contained in the Company&amp;#146;s Form 10-K filed with the SEC as of and&#13;for the year ended December 31, 2012. In the opinion of management, all adjustments necessary for the financial statements to be&#13;not misleading for the interim periods presented have been reflected herein. The results of operations for interim periods are&#13;not necessarily indicative of the results to be expected for the full year.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <OPRX:SignificantAccountingPolicyPoliciesTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounting Basis&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company uses the accrual basis of accounting&#13;and accounting principles generally accepted in the United States of America (&amp;#147;GAAP&amp;#148; accounting). The Company has adopted&#13;a December 31 fiscal year end.&lt;/p&gt;</OPRX:SignificantAccountingPolicyPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The financial statements&#13;reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation&#13;(a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;For purposes of the&#13;accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months&#13;or less to be cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The fair value of cash,&#13;accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable &amp;#150; related&#13;party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term&#13;nature. The fair value of long-term debt, which approximates its carrying value, is based on current rates at which the Company&#13;could borrow funds with similar remaining maturities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Accounts&#13;Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period&#13;the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables&#13;based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience&#13;is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly&#13;assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables&#13;or reserve estimates. Bad debt expense was $0 for the six months ended June 30, 2013 and 2012, respectively. The allowance for&#13;doubtful accounts was $0 as of June 30, 2013 and December 31, 2012, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The capital assets&#13;are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for&#13;book purposes.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All revenue is recognized when it is earned.&#13;Revenues are generated either through the Company&amp;#146;s website activities, in which we earn revenue from advertising and lead&#13;generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons,&#13;and vouchers that enable our customers to save money on medical products and services. The Company&amp;#146;s processes are monitored&#13;by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Company&amp;#146;s&#13;account.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company&amp;#146;s&#13;key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that&#13;can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company seeks to&#13;educate team members through understanding of all market dynamics that have the potential to affect the business both short term&#13;and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as&#13;other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission&#13;through technology, better user experiences and new ways to engage industries to provide new support for patients needing their&#13;products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide&#13;robust opportunities and growth during the next five years.&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income taxes are computed using the asset and&#13;liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the&#13;differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted&#13;tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence,&#13;are not expected to be realized.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Concentration of Credit Risks&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company maintains&#13;its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not&#13;experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences&#13;financial difficulties.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:UseOfEstimates contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The preparation of&#13;financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of&#13;revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives&#13;of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Earnings Per Common and Common Equivalent&#13;Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The computation of&#13;basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The&#13;computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year&#13;plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the&#13;average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents&#13;are not included in the diluted earnings per share calculation for June 30, 2012 since their effect is anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company continually&#13;monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable.&#13;When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining&#13;whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the&#13;future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess&#13;of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount&#13;or the fair value less costs to sell.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Recently Issued Accounting Guidance&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company does not&#13;expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#146;s results of&#13;operations, financial position or cash flow.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <dei:CurrentFiscalYearEndDate contextRef="From2013-01-01to2013-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:ProvisionForDoubtfulAccounts>
    <OPRX:PrepaidExpensesTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;Prepaid expenses consisted&#13;of the following as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 54%"&gt;Insurance&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;6,584&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;6,437&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;44,086&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;31,672&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Legal&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;25,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total prepaid expenses&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;55,719&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;68,158&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:PrepaidExpensesTextBlock>
    <OPRX:ScheduleOfPrepaidExpensesTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 54%"&gt;Insurance&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;6,584&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;6,437&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;44,086&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;31,672&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Legal&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;25,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total prepaid expenses&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;55,719&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;68,158&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfPrepaidExpensesTableTextBlock>
    <OPRX:Insurance contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">6584</OPRX:Insurance>
    <OPRX:Insurance contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6437</OPRX:Insurance>
    <OPRX:Rent contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">5049</OPRX:Rent>
    <OPRX:Rent contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">5049</OPRX:Rent>
    <OPRX:ConsultingExpense contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">44086</OPRX:ConsultingExpense>
    <OPRX:ConsultingExpense contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">31672</OPRX:ConsultingExpense>
    <OPRX:LegalCosts contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">0</OPRX:LegalCosts>
    <OPRX:LegalCosts contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">25000</OPRX:LegalCosts>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company owned equipment recorded at cost&#13;which consisted of the following as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Subtotal&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(15,577&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(12,763&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Property and equipment, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;17,871&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;20,685&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense was $1,407 and $1,412&#13;for the three months ended June 30, 2013 and 2012, respectively. Depreciation expense was $2,814 and $2,712 for the six months&#13;ended June 30, 2013 and 2012, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <OPRX:ScheduleOfPropertyEquipmentTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Subtotal&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(15,577&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(12,763&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Property and equipment, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;17,871&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;20,685&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfPropertyEquipmentTextBlock>
    <us-gaap:Depreciation contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">2814</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">1407</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">1412</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">2712</us-gaap:Depreciation>
    <OPRX:ComputerEquipmentGross contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">22360</OPRX:ComputerEquipmentGross>
    <OPRX:ComputerEquipmentGross contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">22360</OPRX:ComputerEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">11088</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">11088</us-gaap:FurnitureAndFixturesGross>
    <OPRX:SubtotalOfPropertyEquipmentCost contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">33448</OPRX:SubtotalOfPropertyEquipmentCost>
    <OPRX:SubtotalOfPropertyEquipmentCost contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">33448</OPRX:SubtotalOfPropertyEquipmentCost>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">-15577</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-12763</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <OPRX:WebsiteDevelopmentTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has capitalized costs in developing&#13;their website and web-based products, which consisted of the following as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;OptimizeRx web development&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;SampleMD web development&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;602,517&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;602,517&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Subtotal, web development costs&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;756,650&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;756,650&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(375,497&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(310,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Impairment&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Web development costs, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;322,070&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;387,215&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization is recorded using the straight-line&#13;method over a period of five years. The Company determined that the original OptimizeRx website was no longer useful so the remaining&#13;unamortized balance of $59,083 was impaired as of December 31, 2010. Amortization expense for the web development costs was $32,572&#13;and $32,241 for the three months ended June 30, 2013 and 2012, respectively. Amortization expense for the web development costs&#13;was $65,145 and $63,288 for the six months ended June 30, 2013 and 2012, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:WebsiteDevelopmentTextBlock>
    <OPRX:ScheduleOfWebsiteDevelopmentCostsTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;OptimizeRx web development&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;SampleMD web development&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;602,517&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;602,517&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Subtotal, web development costs&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;756,650&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;756,650&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(375,497&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(310,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Impairment&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Web development costs, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;322,070&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;387,215&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfWebsiteDevelopmentCostsTableTextBlock>
    <OPRX:WebsiteDevelopmentCost1 contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">154133</OPRX:WebsiteDevelopmentCost1>
    <OPRX:WebsiteDevelopmentCost1 contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">154133</OPRX:WebsiteDevelopmentCost1>
    <OPRX:WebsiteDevelopmentCost2 contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">602517</OPRX:WebsiteDevelopmentCost2>
    <OPRX:WebsiteDevelopmentCost2 contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">602517</OPRX:WebsiteDevelopmentCost2>
    <OPRX:SubtotalofWebsiteDevelopmentCosts contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">756650</OPRX:SubtotalofWebsiteDevelopmentCosts>
    <OPRX:SubtotalofWebsiteDevelopmentCosts contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">756650</OPRX:SubtotalofWebsiteDevelopmentCosts>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">-375497</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-310352</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">59083</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-59083</us-gaap:UnamortizedDebtIssuanceExpense>
    <OPRX:WebsiteDevelopmenCostNet contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">322070</OPRX:WebsiteDevelopmenCostNet>
    <OPRX:WebsiteDevelopmenCostNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">387215</OPRX:WebsiteDevelopmenCostNet>
    <OPRX:AmortizationExpenseOfWebsite contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">65145</OPRX:AmortizationExpenseOfWebsite>
    <OPRX:AmortizationExpenseOfWebsite contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">32572</OPRX:AmortizationExpenseOfWebsite>
    <OPRX:AmortizationExpenseOfWebsite contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">32241</OPRX:AmortizationExpenseOfWebsite>
    <OPRX:AmortizationExpenseOfWebsite contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">63288</OPRX:AmortizationExpenseOfWebsite>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 26, 2010, the Company acquired from&#13;an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently&#13;in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000&#13;stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the&#13;related party.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has capitalized costs in purchasing&#13;the SampleMD patent, which consisted of the following as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Patent rights and intangible assets&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;968,278&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(165,142&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(136,764&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Patent rights and intangible assets, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;803,136&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;793,236&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company began amortizing the patent, using&#13;the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. In 2013, the Company&#13;began incurring costs related to defense of the patent. These costs have been capitalized and will be amortized using the straight-line&#13;method over the remaining useful life of the original patent. Amortization expense was $14,246 and $13,676 for the three months&#13;ended June 30, 2013 and 2012, respectively. Amortization expense was $28,378 and $27,352 for the six months ended June 30, 2013&#13;and 2012, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Patent rights and intangible assets&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;968,278&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(165,142&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(136,764&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Patent rights and intangible assets, net&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;803,136&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;793,236&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">968278</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">930000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
    <OPRX:AccumulatedAmortizationOfPatentRights contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">-165142</OPRX:AccumulatedAmortizationOfPatentRights>
    <OPRX:AccumulatedAmortizationOfPatentRights contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-136764</OPRX:AccumulatedAmortizationOfPatentRights>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">803136</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">793236</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <OPRX:CommonStockSharesGrantedToAcquireExclusivePatentRights contextRef="AsOf2010-04-26" unitRef="Shares" decimals="INF">300000</OPRX:CommonStockSharesGrantedToAcquireExclusivePatentRights>
    <OPRX:OptionsGrantedToAcquireExclusivePatentRights contextRef="AsOf2010-04-26" unitRef="Shares" decimals="INF">200000</OPRX:OptionsGrantedToAcquireExclusivePatentRights>
    <OPRX:OptionsGrantedToAcquireExclusivePatentRightsValue contextRef="AsOf2010-04-26" unitRef="USD" decimals="0">360000</OPRX:OptionsGrantedToAcquireExclusivePatentRightsValue>
    <OPRX:CommonStockSharesGrantedToAcquireExclusivePatentRightsValue contextRef="AsOf2010-04-26" unitRef="USD" decimals="0">570000</OPRX:CommonStockSharesGrantedToAcquireExclusivePatentRightsValue>
    <OPRX:AmortizationExpenseofPatent contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">28378</OPRX:AmortizationExpenseofPatent>
    <OPRX:AmortizationExpenseofPatent contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">14246</OPRX:AmortizationExpenseofPatent>
    <OPRX:AmortizationExpenseofPatent contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">13676</OPRX:AmortizationExpenseofPatent>
    <OPRX:AmortizationExpenseofPatent contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">27352</OPRX:AmortizationExpenseofPatent>
    <OPRX:AccruedExpenseTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 14, 2013, the Company hired a new&#13;CEO. The employment agreement requires annual compensation of $175,000 that will be accrued and deferred until at least January&#13;1, 2014. Additionally, the agreement requires the issuance of 2,000,000 options with an exercise price of $1.00 for a term of five&#13;years. The options are not exercisable until at least January 1, 2014. The Company has accrued $87,500, or six months compensation,&#13;at June 30, 2013.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued expenses consisted of the following&#13;as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Accrued compensation&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;87,500&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accrued audit fees&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accrued expenses&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;87,500&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:AccruedExpenseTextBlock>
    <OPRX:ScheduleOfAccruedExpensesTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 55%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Accrued compensation&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;87,500&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accrued audit fees&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accrued expenses&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;87,500&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfAccruedExpensesTableTextBlock>
    <OPRX:AccruedCompensation contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">87500</OPRX:AccruedCompensation>
    <OPRX:AccruedCompensation contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</OPRX:AccruedCompensation>
    <OPRX:AccruedAuditFees contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">0</OPRX:AccruedAuditFees>
    <OPRX:AccruedAuditFees contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6000</OPRX:AccruedAuditFees>
    <OPRX:AccruedExpenses contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">87500</OPRX:AccruedExpenses>
    <OPRX:AccruedExpenses contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">6000</OPRX:AccruedExpenses>
    <OPRX:AnnualCompensationForCeo contextRef="AsOf2013-01-14" unitRef="USD" decimals="0">175000</OPRX:AnnualCompensationForCeo>
    <OPRX:IssuanceOfStockOptionsToCeoShares contextRef="AsOf2013-01-14" unitRef="Shares" decimals="INF">2000000</OPRX:IssuanceOfStockOptionsToCeoShares>
    <OPRX:IssuanceOfStockOptionsToCeoParValue contextRef="AsOf2013-01-14" unitRef="Shares" decimals="INF">1.00</OPRX:IssuanceOfStockOptionsToCeoParValue>
    <OPRX:TermOfOptionsAgreement contextRef="AsOf2013-01-14">P5Y</OPRX:TermOfOptionsAgreement>
    <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The Company has signed several contracts with customers&#13;for either the distribution or redemption of coupons. The payments are not taken into revenue until either the coupon is distributed&#13;to a patient or the coupon has been redeemed depending on the specific contract. The distributions and redemptions are tracked&#13;by the company&amp;#146;s administrative tool. Additionally, customer setup contracts that have been paid in full are deferred until&#13;the Company has completed the obligations of the contacts. Deferred revenue was $42,620 and $49,252 as of June 30, 2013 and December&#13;31, 2012, respectively&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p&gt;&lt;/p&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During the year ended December 31, 2010, the Company&#13;acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD&#13;patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition&#13;to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a&#13;payable to the related party.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <OPRX:ShareBasedCompensationArrangementOfStockOptionsIssued contextRef="AsOf2010-12-31" unitRef="Shares" decimals="INF">300000</OPRX:ShareBasedCompensationArrangementOfStockOptionsIssued>
    <OPRX:CommonStockIssuedForPurchaseOfPatent contextRef="AsOf2010-12-31" unitRef="Shares" decimals="INF">200000</OPRX:CommonStockIssuedForPurchaseOfPatent>
    <OPRX:ShareBasedCompensationArrangementOfStockOptionsValue contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">360000</OPRX:ShareBasedCompensationArrangementOfStockOptionsValue>
    <OPRX:CommonStockValueOnGrantDate contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">570000</OPRX:CommonStockValueOnGrantDate>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;OptimizeRx&#13;Corporation has 500,000,000 shares of $.001 par value common stock authorized as of June 30, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;There&#13;were 14,252,496 and 14,232,496 common shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 1, 2012, the Company entered into a consulting agreement with North Coast Advisors, Inc. for various services. The Company&#13;agreed to issue 40,000 shares of common stock as of the date of the contract. However, these shares were not issued until July&#13;12, 2012. The Company also agreed to issue an additional 40,000 shares every six months in alignment with the agreement renewal&#13;up to the two years of the agreement. The first 40,000 shares were valued at the Company&amp;#146;s common stock price as of the date&#13;of the contract, which was $1.12/share and has been expensed. No additional shares were issued and the agreement was voided and&#13;replaced by a new agreement as noted below.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 1, 2013, the Company entered into a consulting agreement with North Coast Advisors, Inc. for various services. The Company&#13;agreed to issue 20,000 shares of common stock as of the date of the contract. The Company also agreed to issue an additional 20,000&#13;shares every six months in alignment with the agreement renewal up to the two years of the agreement. The first 20,000 shares&#13;were valued at the Company&amp;#146;s common stock price as of the date of the contract, which was $1.945/share and has been expensed.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <OPRX:StockIssuedUnderConsultingAgreement contextRef="AsOf2012-07-12" unitRef="Shares" decimals="INF">40000</OPRX:StockIssuedUnderConsultingAgreement>
    <OPRX:StockIssuedUnderConsultingAgreement contextRef="AsOf2013-06-01" unitRef="Shares" decimals="INF">20000</OPRX:StockIssuedUnderConsultingAgreement>
    <OPRX:StockGrantedDuringPeriodSharesUnderConsultingAgreementEverySixMonths contextRef="AsOf2012-06-01" unitRef="Shares" decimals="INF">40000</OPRX:StockGrantedDuringPeriodSharesUnderConsultingAgreementEverySixMonths>
    <OPRX:StockGrantedDuringPeriodSharesUnderConsultingAgreementEverySixMonths contextRef="AsOf2013-06-01" unitRef="Shares" decimals="INF">20000</OPRX:StockGrantedDuringPeriodSharesUnderConsultingAgreementEverySixMonths>
    <OPRX:StockIssuedUnderConsultingAgreementParValue contextRef="AsOf2012-07-12" unitRef="Shares" decimals="INF">1.12</OPRX:StockIssuedUnderConsultingAgreementParValue>
    <OPRX:StockIssuedUnderConsultingAgreementParValue contextRef="AsOf2013-06-01" unitRef="Shares" decimals="INF">1.945</OPRX:StockIssuedUnderConsultingAgreementParValue>
    <OPRX:TermOfConsultingAgreement contextRef="AsOf2012-06-01">P2Y</OPRX:TermOfConsultingAgreement>
    <OPRX:TermOfConsultingAgreement contextRef="AsOf2013-06-01">P2Y</OPRX:TermOfConsultingAgreement>
    <us-gaap:PreferredStockTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Series&#13;A Preferred&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in&#13;net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend.&#13;In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of&#13;seven years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock&#13;at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash&#13;or shares of the Company's common stock at management&amp;#146;s discretion. If after the conversion eligibility date, the market&#13;price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds&#13;100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series&#13;A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company&#13;at the stated value of such share at a $1 conversion price.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Series&#13;A Preferred Continued&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject&#13;to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth&#13;in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the&#13;registration of the conversion.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;May 12, 2010, the Company&amp;#146;s Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual&#13;dividends. On November 16, 2010, the Company&amp;#146;s Board declared and issued 173,922 common shares for its semi-annual dividend&#13;payment. On March 25, 2011, the Company&amp;#146;s Board declared and issued 176,768 common shares for its semi-annual dividend payment.&#13;On September 21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment. The&#13;Company has undeclared dividends that were due in February and September 2012 totaling $350,000 and undeclared dividends of $175,000&#13;that were due in February 2013 for a total undeclared amount of $525,000 as of June 30, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Series&#13;B Preferred&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended December 31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,000,000 shares&#13;of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 3,000,000 shares of common&#13;stock at an exercise price of $3 for a period of seven years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally,&#13;3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common&#13;stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants.&#13;Equity issuance costs of $350,000 were allocated to the preferred stock.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the quarter ended September 30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible&#13;to 1,000,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000&#13;shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock&#13;and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common&#13;stock warrants. See Note 12.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock&#13;at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash&#13;or shares of the Company's common stock at management&amp;#146;s discretion. If after the conversion eligibility date, the market&#13;price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds&#13;100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series&#13;B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company&#13;at the stated value of such share at a $1.50 conversion price.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Series&#13;B Preferred Continued&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;holder may cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject&#13;to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth&#13;in the shareholder agreement. On March 25, 2011, the Company&amp;#146;s Board declared and issued 75,758 common shares for its semi-annual&#13;dividend payment. On September 21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend&#13;payment. The Company has undeclared dividends that were due in February and September 2012 totaling $150,000 and undeclared dividends&#13;of $75,000 that were due in February 2013 for a total undeclared amount of $225,000 as of June 30, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <OPRX:PreferredStockSeriesASharesIssuedForProceeds contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">35</OPRX:PreferredStockSeriesASharesIssuedForProceeds>
    <OPRX:PreferredStockSeriesAValue contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">3500000</OPRX:PreferredStockSeriesAValue>
    <OPRX:PreferredStockSeriesAStockIssuanceExpense contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">515000</OPRX:PreferredStockSeriesAStockIssuanceExpense>
    <OPRX:PreferredStockSeriesAStockNetProceeds contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">2985000</OPRX:PreferredStockSeriesAStockNetProceeds>
    <OPRX:ConvertiblePreferredStockSeriesASharesIssuedUponConversion contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">3500000</OPRX:ConvertiblePreferredStockSeriesASharesIssuedUponConversion>
    <OPRX:PreferredStockSeriesAStockDividendRatePercentage contextRef="From2008-01-01to2008-12-31" unitRef="Percent" decimals="INF">.10</OPRX:PreferredStockSeriesAStockDividendRatePercentage>
    <OPRX:CommonStockWarrantsIssuedForPurchase contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">6000000</OPRX:CommonStockWarrantsIssuedForPurchase>
    <OPRX:CommonStockWarrantsIssuedForPurchase contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">3000000</OPRX:CommonStockWarrantsIssuedForPurchase>
    <OPRX:CommonStockWarrantsExercisePrice contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">2.00</OPRX:CommonStockWarrantsExercisePrice>
    <OPRX:CommonStockWarrantsExercisePrice contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">3.00</OPRX:CommonStockWarrantsExercisePrice>
    <OPRX:CommonStockWarrantsExpiration contextRef="From2008-01-01to2008-12-31">P7Y</OPRX:CommonStockWarrantsExpiration>
    <OPRX:CommonStockWarrantsExpiration contextRef="From2010-01-01to2010-12-31">P7Y</OPRX:CommonStockWarrantsExpiration>
    <OPRX:PreferredStockSeriesBSharesIssuedForProceeds contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">15</OPRX:PreferredStockSeriesBSharesIssuedForProceeds>
    <OPRX:PreferredStockSeriesBValue contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1500000</OPRX:PreferredStockSeriesBValue>
    <OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">1000000</OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion>
    <OPRX:PreferredStockSeriesBStockDividendRatePercentage contextRef="From2010-01-01to2010-12-31" unitRef="Percent" decimals="INF">10</OPRX:PreferredStockSeriesBStockDividendRatePercentage>
    <OPRX:CommonStockWarrantsIssued contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">3000000</OPRX:CommonStockWarrantsIssued>
    <OPRX:PreferredStockSeriesBStockIssuanceExpense contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">350000</OPRX:PreferredStockSeriesBStockIssuanceExpense>
    <OPRX:PreferredStockSeriesBStockNetProceeds contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1500000</OPRX:PreferredStockSeriesBStockNetProceeds>
    <OPRX:PreferredStockValueOnGrantDate contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">341100</OPRX:PreferredStockValueOnGrantDate>
    <OPRX:CommonStockWarrantValueOnGrantDate contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1158900</OPRX:CommonStockWarrantValueOnGrantDate>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2011-03-25" unitRef="Shares" decimals="INF">176768</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2011-09-21" unitRef="Shares" decimals="INF">156306</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2010-05-12" unitRef="Shares" decimals="INF">236598</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2010-11-16" unitRef="Shares" decimals="INF">173922</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB contextRef="AsOf2011-03-25" unitRef="Shares" decimals="INF">75758</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB contextRef="AsOf2011-09-21" unitRef="Shares" decimals="INF">66988</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB>
    <OPRX:UndeclaredDividendsPreferredStockValue contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">225000</OPRX:UndeclaredDividendsPreferredStockValue>
    <OPRX:UndeclaredDividendsPreferredStockValue contextRef="AsOf2012-09-30" unitRef="USD" decimals="0">150000</OPRX:UndeclaredDividendsPreferredStockValue>
    <OPRX:UndeclaredDividendsPreferredStockValue contextRef="AsOf2013-02-28" unitRef="USD" decimals="0">75000</OPRX:UndeclaredDividendsPreferredStockValue>
    <OPRX:StockOptionsWarrantsTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for employee stock-based&#13;compensation in accordance with the guidance of ASC Topic 718: Compensation - Stock Compensation, which requires all share-based&#13;payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their&#13;fair values.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows ASC Topic 505-50, formerly&#13;EITF 96-18, &amp;#147;Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with&#13;Selling Goods and Services,&amp;#148; for stock options and warrants issued to consultants and other non-employees. In accordance&#13;with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to the Company are accounted&#13;for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can&#13;be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense and additional&#13;paid-in capital over the period during which services are rendered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 31, 2011, the Company issued 285,000&#13;stock options to 3 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing&#13;model with the following assumptions: dividend yield of 0%, expected volatility of 218%, risk-free interest rate of 1.68% and expected&#13;life of 60 months. The total value of the options was $320,585. The options vest over one year. The Company recognized share-based&#13;compensation expense of $187,005 during the year ended December 31, 2011. The remaining balance of $133,580 was recognized over&#13;the first five months of 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended December 31, 2011,&#13;the Company issued 20,000 stock options to 2 employees at an exercise price of $1.00. The options were valued on the grant date&#13;using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 204-205%,&#13;risk-free interest rate of 0.88-0.93% and expected life of 60 months. The total value of the options was $19,270. The options vest&#13;over one year. &lt;font style="color: black; background-color: white"&gt; &lt;/font&gt;&lt;font style="background-color: white"&gt;The Company&lt;font style="color: black"&gt;&#13;recognized share-based compensation expense of $2,480 during the year ended &lt;/font&gt;December 31, 2011 a&lt;font style="color: black"&gt;nd&#13;$9,633 during the &lt;/font&gt;six months ended June 30, 2012&lt;font style="color: black"&gt;. The remaining balance was recognized during&#13;the remainder of 2012. &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 21, 2011, the Company issued 100,000&#13;stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes&#13;option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 205%, risk-free interest rate&#13;of 0.92% and expected life of 60 months. &lt;font style="background-color: white"&gt; The Company recognized expenses of $8,346 during&#13;the year ended December 31, 2011 and $50,078 during the six months ended June&lt;/font&gt; 30, 2012.&lt;font style="background-color: white"&gt;&#13;The remaining balance was recognized during the remainder of 2012.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended March 31, 2012, the&#13;Company issued 50,000 stock options to 4 non-employees at an exercise price of $0.89. The options were valued on the grant date&#13;using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 198%,&#13;risk-free interest rate of 0.65% and expected life of 48 months. The total value of the options was $35,091. The options vest over&#13;4 months. The Company recognized share-based compensation expense of $35,091 during the six months ended June 30, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended December 31, 2012,&#13;the Company issued 25,000 stock options to a non-employee at an exercise price of $1.58. The options were valued on the grant date&#13;using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 200%,&#13;risk-free interest rate of 0.67% and expected life of 60 months. The total value of the options was $40,007. The options vest over&#13;1 year. The Company recognized share-based compensation expense of $8,335 during the three months ended December 31, 2012 and $20,004&#13;during the six months ended June 30, 2013. The remaining balance will be recognized over the remainder of 2013.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company had the following options outstanding&#13;as of June 30, 2013:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding-left: 5.75pt; width: 47%; padding-right: 5.75pt; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.75pt; width: 28%; padding-right: 5.75pt; vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number of Options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.75pt; width: 25%; padding-right: 5.75pt; vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average exercise&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, January 1, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;405,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$ 1.01 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;75,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.17 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(455,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(.98)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.58 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt double; text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt double; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$ 1.58 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company had the following warrants outstanding&#13;as of June 30, 2013:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;Weighted average exercise price&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 33%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, January 1, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 31%"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 30%"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:StockOptionsWarrantsTextBlock>
    <OPRX:ScheduleOfOptionsTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="padding-left: 5.75pt; width: 47%; padding-right: 5.75pt; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.75pt; width: 28%; padding-right: 5.75pt; vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number of Options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.75pt; width: 25%; padding-right: 5.75pt; vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average exercise&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, January 1, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;405,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$ 1.01 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;75,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.17 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(455,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(.98)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.58 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt double; text-align: right; padding-left: 5.75pt; padding-right: 4.1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1.5pt double; text-align: right; padding-left: 5.75pt; padding-right: 5.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$ 1.58 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfOptionsTextBlock>
    <OPRX:ScheduleOfWarrantsTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;Weighted average exercise price&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 33%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, January 1, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 31%"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 30%"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired - 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;14,344,434&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;2.41&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfWarrantsTextBlock>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company signed a lease for new office space&#13;on December 1, 2011 at an approximate rent of $5,000 per month. The new offices are in Rochester, Michigan. The lease is for three&#13;years with an option to renew for an additional two years at approximately $5,200 per month with six months advance notice to exercise&#13;the option. Minimum annual rent is as follows for the initial term of the lease:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right; width: 49%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Year ended December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 47%"&gt;60,591&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2014&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;55,542&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;2015&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total lease commitment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;116,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:ScheduleOfRentExpenseTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right; width: 49%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Year ended December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 47%"&gt;60,591&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2014&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;55,542&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;2015&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total lease commitment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;116,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfRentExpenseTableTextBlock>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">60591</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">55542</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">0</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:TotalLeaseCommitmentDue contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">116133</OPRX:TotalLeaseCommitmentDue>
    <OPRX:MonthlyRentDue contextRef="From2011-12-01to2014-12-01" unitRef="USD" decimals="0">5000</OPRX:MonthlyRentDue>
    <OPRX:MonthlyRentDue contextRef="From2014-12-02to2016-12-01" unitRef="USD" decimals="0">25000</OPRX:MonthlyRentDue>
    <OPRX:TermOfLease contextRef="From2011-12-01to2014-12-01">P3Y</OPRX:TermOfLease>
    <OPRX:TermOfLease contextRef="From2014-12-02to2016-12-01">P2Y</OPRX:TermOfLease>
    <OPRX:MajorCustomersTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;The Company had two major customers that accounted&#13;for 63% and two major customers that accounted for 53% of the Company&amp;#146;s revenues for the six months ended June 30, 2013 and&#13;2012, respectively. The Company expects to continue to maintain these relationships with the customers.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p&gt;&lt;/p&gt;</OPRX:MajorCustomersTextBlock>
    <OPRX:MajorCustomers contextRef="From2013-01-01to2013-06-30" unitRef="Percent" decimals="INF">.63</OPRX:MajorCustomers>
    <OPRX:MajorCustomers contextRef="From2012-01-01to2012-06-30" unitRef="Percent" decimals="INF">.53</OPRX:MajorCustomers>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the six months ended June 30, 2013, the&#13;Company incurred net income of approximately $249,000 but has no tax liability. The Company began operations in 2007 and has previous&#13;net operating loss carry-forwards of $13,843,000 through December 31, 2012. The cumulative loss of $13,594,000 will be carried&#13;forward and can be used through the year 2033 to offset future taxable income. In the future, the cumulative net operating loss&#13;carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between&#13;book and tax reporting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for Federal income tax consists&#13;of the following for the six months ended June 30, 2013 and 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Current operations&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;(84,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;102,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;84,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(102,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net provision for federal income tax&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The cumulative tax effect at the expected rate&#13;of 34% of significant items comprising our net deferred tax amount is as follows as of June 30, 2013 and December 31, 2012:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Deferred tax asset attributable to:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Net operating loss carryover&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,622,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,706,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,622,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,706,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Due to the change in ownership provisions of&#13;the Tax Reform Act of 1986, net operating loss carry forwards of approximately $13,594,000 for Federal income tax reporting purposes&#13;are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use&#13;in future years.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Current operations&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;(84,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;102,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;84,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(102,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net provision for federal income tax&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 50%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Deferred tax asset attributable to:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Net operating loss carryover&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,622,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,706,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,622,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,706,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">-84000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">102000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">84000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-102000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <OPRX:NetFederalIncomeTax contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">0</OPRX:NetFederalIncomeTax>
    <OPRX:NetFederalIncomeTax contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</OPRX:NetFederalIncomeTax>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">4622000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">4706000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">-4622000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-4706000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <OPRX:OperatingLossCarryForward contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">249000</OPRX:OperatingLossCarryForward>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2013-06-30" unitRef="USD" decimals="0">13594000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">13843000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardExpirationDate contextRef="From2013-01-01to2013-06-30">2033-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2013-01-01to2013-06-30" unitRef="Percent" decimals="INF">.34</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <OPRX:ContingentLiabilityTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On January 14, 2013, the Company hired a new CEO.&#13;The employment agreement requires annual compensation of $175,000 that will be accrued and deferred until at least January 1,&#13;2014. Additionally, the agreement requires the issuance of 2,000,000 options with an exercise price of $1.00 for a term of five&#13;years. The options are not exercisable until at least January 1, 2014, and are only exercisable after reaching certain financial&#13;terms and conditions. Due to these restrictions, no accrual has been made for the issuance of these options&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p&gt;&lt;/p&gt;</OPRX:ContingentLiabilityTextBlock>
    <OPRX:ExercisableDate contextRef="AsOf2013-01-14">2014-01-01</OPRX:ExercisableDate>
    <OPRX:OperatingExpensesTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Operating expenses consisted of the following&#13;for the three months and six months ended June 30, 2013 and 2012, respectively:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-indent: -13.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;Three months ended&lt;br /&gt;June 30&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;Six months ended &lt;br /&gt;June 30&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 52%"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;3,825&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;32,651&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;7,165&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;43,921&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;79,190&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;34,632&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;132,288&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;72,635&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;19,722&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,220&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;40,129&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Salaries, wages and benefits&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;320,188&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;294,570&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;695,259&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;601,465&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;30,296&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;32,066&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;48,226&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;47,329&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;96,337&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;93,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Stock-based compensation&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;10,002&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;100,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;20,004&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;228,383&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Revenue share expense&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;197,200&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;8,135&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;237,403&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;8,135&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;General and administrative&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;56,465&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;57,110&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;265,257&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;134,160&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Operating Expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;749,966&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;591,630&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,524,138&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,221,952&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:OperatingExpensesTextBlock>
    <OPRX:ScheduleOfOperatingCostAndExpenseByComponentTextBlock contextRef="From2013-01-01to2013-06-30">&lt;table cellspacing="0" cellpadding="0" align="center" style="width: 65%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;Three months ended&lt;br /&gt;June 30&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;Six months ended &lt;br /&gt;June 30&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2013&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 52%"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;3,825&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;32,651&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;7,165&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;43,921&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;79,190&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;34,632&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;132,288&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;72,635&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;19,722&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,220&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;40,129&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Salaries, wages and benefits&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;320,188&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;294,570&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;695,259&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;601,465&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;30,296&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;32,066&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;48,226&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;47,329&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;96,337&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;93,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Stock-based compensation&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;10,002&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;100,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;20,004&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;228,383&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Revenue share expense&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;197,200&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;8,135&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;237,403&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;8,135&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;General and administrative&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;56,465&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;57,110&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;265,257&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;134,160&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Operating Expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;749,966&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;591,630&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,524,138&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,221,952&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfOperatingCostAndExpenseByComponentTextBlock>
    <us-gaap:AdvertisingExpense contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">7165</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">3825</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">32651</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">43921</us-gaap:AdvertisingExpense>
    <us-gaap:ProfessionalFees contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">132288</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">79190</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">34632</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">72635</us-gaap:ProfessionalFees>
    <OPRX:Consulting contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">40129</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">19722</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">1220</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">7835</OPRX:Consulting>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">695259</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">320188</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">294570</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">601465</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:PaymentsForRent contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">30296</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">15148</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">15148</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">32066</us-gaap:PaymentsForRent>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">20004</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">10002</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">100835</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">228383</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2011-01-01to2011-12-31_ThreeEmployeesStockOptionsMember" unitRef="USD" decimals="0">187005</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-05-30_ThreeEmployeesStockOptionsMember" unitRef="USD" decimals="0">133580</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2011-01-01to2011-12-31_TwoEmployeesStockOptionsMember" unitRef="USD" decimals="0">2480</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-06-30_TwoEmployeesStockOptionsMember" unitRef="USD" decimals="0">9633</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2011-01-01to2011-12-31_IndividualStockOptionsMember" unitRef="USD" decimals="0">8346</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-06-30_IndividualStockOptionsMember" unitRef="USD" decimals="0">50078</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-06-30_FourNonEmployeesStockOptionsMember" unitRef="USD" decimals="0">35091</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-10-01to2012-12-31_NonEmployeeStockOptionsMember" unitRef="USD" decimals="0">8335</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-06-30_NonEmployeeStockOptionsMember" unitRef="USD" decimals="0">20004</us-gaap:ShareBasedCompensation>
    <OPRX:RevenueShareExpense contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">237403</OPRX:RevenueShareExpense>
    <OPRX:RevenueShareExpense contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">197200</OPRX:RevenueShareExpense>
    <OPRX:RevenueShareExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">8135</OPRX:RevenueShareExpense>
    <OPRX:RevenueShareExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">8135</OPRX:RevenueShareExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">265257</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-04-01to2013-06-30" unitRef="USD" decimals="0">56465</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">57110</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">134160</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2013-01-01to2013-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In accordance with ASC 855-10, the Company has analyzed&#13;its operations subsequent to June 30, 2013 through the date these financial statements were issued and has determined that it&#13;does not have any material subsequent events to disclose in these financial statements other than the events described above.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <OPRX:OptionsIssued contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">25000</OPRX:OptionsIssued>
    <OPRX:OptionsIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">405000</OPRX:OptionsIssued>
    <OPRX:OptionsIssued contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">25000</OPRX:OptionsIssued>
    <OPRX:OptionsGranted contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">75000</OPRX:OptionsGranted>
    <OPRX:OptionsGranted contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionsGranted>
    <OPRX:OptionsExercised contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionsExercised>
    <OPRX:OptionsExercised contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionsExercised>
    <OPRX:OptionsExpired contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">-455000</OPRX:OptionsExpired>
    <OPRX:OptionsExpired contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionsExpired>
    <OPRX:OptionGrantedPrice contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">1.17</OPRX:OptionGrantedPrice>
    <OPRX:OptionGrantedPrice contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionGrantedPrice>
    <OPRX:OptionExercisedPrice contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionExercisedPrice>
    <OPRX:OptionExercisedPrice contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionExercisedPrice>
    <OPRX:OptionExpiredPrice contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">-0.98</OPRX:OptionExpiredPrice>
    <OPRX:OptionExpiredPrice contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:OptionExpiredPrice>
    <OPRX:WarrantsIssued contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">14344434</OPRX:WarrantsIssued>
    <OPRX:WarrantsIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">14344434</OPRX:WarrantsIssued>
    <OPRX:WarrantsIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">14344434</OPRX:WarrantsIssued>
    <OPRX:WarrantsIssued contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">14344434</OPRX:WarrantsIssued>
    <OPRX:WarrantsIssuedPrice contextRef="AsOf2013-06-30" unitRef="USDPShares" decimals="INF">2.41</OPRX:WarrantsIssuedPrice>
    <OPRX:WarrantsIssuedPrice contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">2.41</OPRX:WarrantsIssuedPrice>
    <OPRX:WarrantsIssuedPrice contextRef="AsOf2011-12-31" unitRef="USDPShares" decimals="INF">2.41</OPRX:WarrantsIssuedPrice>
    <OPRX:WarrantsIssuedPrice contextRef="AsOf2012-06-30" unitRef="USDPShares" decimals="INF">2.41</OPRX:WarrantsIssuedPrice>
    <OPRX:WarrantsGranted contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsGranted>
    <OPRX:WarrantsGranted contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsGranted>
    <OPRX:WarrantsGrantedPrice contextRef="From2013-01-01to2013-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsGrantedPrice>
    <OPRX:WarrantsGrantedPrice contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsGrantedPrice>
    <OPRX:WarrantsExercised contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsExercised>
    <OPRX:WarrantsExercised contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsExercised>
    <OPRX:WarrantsExercisedPrice contextRef="From2013-01-01to2013-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsExercisedPrice>
    <OPRX:WarrantsExercisedPrice contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsExercisedPrice>
    <OPRX:WarrantsExpired contextRef="From2013-01-01to2013-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsExpired>
    <OPRX:WarrantsExpired contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">0</OPRX:WarrantsExpired>
    <OPRX:WarrantsExpiredPrice contextRef="From2013-01-01to2013-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsExpiredPrice>
    <OPRX:WarrantsExpiredPrice contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">0</OPRX:WarrantsExpiredPrice>
    <OPRX:OptionIssuedPrice contextRef="AsOf2013-06-30" unitRef="Shares" decimals="INF">1.58</OPRX:OptionIssuedPrice>
    <OPRX:OptionIssuedPrice contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">1.01</OPRX:OptionIssuedPrice>
    <OPRX:OptionIssuedPrice contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">1.58</OPRX:OptionIssuedPrice>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-05-31_ThreeEmployeesStockOptionsMember" unitRef="Shares" decimals="INF">1.00</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-12-31_TwoEmployeesStockOptionsMember" unitRef="Shares" decimals="INF">1.00</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-11-21_IndividualStockOptionsMember" unitRef="Shares" decimals="INF">.73</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2012-03-31_FourNonEmployeesStockOptionsMember" unitRef="Shares" decimals="INF">.89</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2012-12-31_NonEmployeeStockOptionsMember" unitRef="Shares" decimals="INF">1.58</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2011-05-31_ThreeEmployeesStockOptionsMember">P1Y</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2011-12-31_TwoEmployeesStockOptionsMember">P1Y</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2012-03-31_FourNonEmployeesStockOptionsMember">P4M</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2012-12-31_NonEmployeeStockOptionsMember">P1Y</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionValueBlackScholesModel contextRef="AsOf2011-05-31_ThreeEmployeesStockOptionsMember" unitRef="USD" decimals="0">320585</OPRX:StockOptionValueBlackScholesModel>
    <OPRX:StockOptionValueBlackScholesModel contextRef="AsOf2011-12-31_TwoEmployeesStockOptionsMember" unitRef="USD" decimals="0">19270</OPRX:StockOptionValueBlackScholesModel>
    <OPRX:StockOptionValueBlackScholesModel contextRef="AsOf2012-03-31_FourNonEmployeesStockOptionsMember" unitRef="USD" decimals="0">35091</OPRX:StockOptionValueBlackScholesModel>
    <OPRX:StockOptionValueBlackScholesModel contextRef="AsOf2012-12-31_NonEmployeeStockOptionsMember" unitRef="USD" decimals="0">40007</OPRX:StockOptionValueBlackScholesModel>
    <OPRX:StockOptionsIssued contextRef="AsOf2011-05-31_ThreeEmployeesStockOptionsMember" unitRef="USD" decimals="0">285000</OPRX:StockOptionsIssued>
    <OPRX:StockOptionsIssued contextRef="AsOf2011-12-31_TwoEmployeesStockOptionsMember" unitRef="USD" decimals="0">20000</OPRX:StockOptionsIssued>
    <OPRX:StockOptionsIssued contextRef="AsOf2011-11-21_IndividualStockOptionsMember" unitRef="USD" decimals="0">100000</OPRX:StockOptionsIssued>
    <OPRX:StockOptionsIssued contextRef="AsOf2012-03-31_FourNonEmployeesStockOptionsMember" unitRef="USD" decimals="0">50000</OPRX:StockOptionsIssued>
    <OPRX:StockOptionsIssued contextRef="AsOf2012-12-31_NonEmployeeStockOptionsMember" unitRef="USD" decimals="0">25000</OPRX:StockOptionsIssued>
    <OPRX:UsefulLifeOfWebsite contextRef="From2013-01-01to2013-06-30">P5Y</OPRX:UsefulLifeOfWebsite>
    <OPRX:CapitalAssetsUsefulLifeMinimum contextRef="From2013-01-01to2013-06-30">P3Y</OPRX:CapitalAssetsUsefulLifeMinimum>
    <OPRX:CapitalAssetsUsefulLifeMaximum contextRef="From2013-01-01to2013-06-30">P7Y</OPRX:CapitalAssetsUsefulLifeMaximum>
    <OPRX:UsefulLifeOfPatent contextRef="From2013-01-01to2013-06-30">P17Y</OPRX:UsefulLifeOfPatent>
</xbrli:xbrl>
